Senseonics Holdings, Inc. SENS Business Segments — Research And Development Expense
Other financials
Where this comes from
Reported directly by Senseonics Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Senseonics Holdings, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Senseonics Holdings, Inc. 's business segments — research and development expense.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Senseonics Holdings, Inc. 's business segments — research and development expense?
- Senseonics Holdings, Inc. (SENS) reported business segments — research and development expense of $8.61M in Q1 2026.
- How has Senseonics Holdings, Inc. 's business segments — research and development expense changed year-over-year?
- Senseonics Holdings, Inc. 's business segments — research and development expense increased by 18.0% year-over-year, from $7.3M to $8.61M.
- What is the long-term trend for Senseonics Holdings, Inc. 's business segments — research and development expense?
- Over 2 years (2023 to 2025), Senseonics Holdings, Inc. 's business segments — research and development expense has grown at a -19.5% compound annual growth rate (CAGR), from $48.75M to $31.59M.
- What does business segments — research and development expense mean?
- This metric represents the expenditures dedicated to the innovation, design, and clinical development of new or improved technologies within the segment. For medical technology firms, this is a critical investment in the product pipeline and long-term competitive advantage. It highlights the company's commitment to advancing its technological capabilities.